The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.
The beginning of the new CPD cycle means it is time to prepare a new professional development plan (PDP) and sketch out areas ...
Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...
Macular degeneration is a leading cause of vision loss, especially in people over the age of 50. It affects the macula, a ...
SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.
SolidddVision smart glasses aim to restore vision for people living with macular degeneration, a condition that affects millions but has no medical cure.
The Brighterside of News on MSN3d
New eye drops successfully treat age-related macular degenerationToll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback